CVS' Q4 2025 saw record revenue, but rising medical costs in Aetna drove a $1B cut to FY 2026 cash flow guidance, now at $9B.

CVS Health reported $2.9 billion in fourth quarter net income as the company begins to get a handle on costs that have hit ...

Some payments that were originally expected in early 2026 instead arrived late in 2025, boosting reported 2025 cash flow but reducing 2026’s starting point. As a result, CVS now guides to at least $9 ...

The healthcare giant outperformed to close out 2025, and expects its finances to improve further this year. Still, proposed ...

CVS Health reported earnings that beat analysts’ expectations and kept its 2026 profit guidance unchanged, results that may ...

The results signal steady progress in the health-care giant's aggressive turnaround plan under CEO David Joyner, who stepped into the role in late 2024.

CVS Health CEO David Joyner told investors on Tuesday that the recently proposed rates for the 2027 Medicare Advantage plan ...

CVS Health's workforce reduction follows a broader pattern of retrenchment across the health insurance sector. Horizon Blue ...

Choose Providence Business First as a preferred news source to see more of our reporting on Google. Aetna returned to ...

CVS Health reaffirmed its guidance for full year 2026 revenue of at least $400 billion and adjusted EPS in the range of $7 to $7.20. Newman commented, "We are encouraged by the strength of our results ...

Feb 10 (Reuters) - CVS Health reported a decline in fourth-quarter profit on Tuesday but beat Wall Street estimates, helped by strength in its pharmacy benefit unit and strong prescription volume at ...